ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Jun 8, 2005
Insider Transaction Report
Form 4
ROLLINS SCOTT A
Sr. VP Drug Dev. & Proj. Man.
Transactions
- Sale
Common Stock, par value $.0001
2005-06-08$22.25/sh−1,900$42,275→ 3,100 total